会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TISSUE-FASTENING ARTICLES AND DEVICES, AND RELATED METHODS
    • 组织紧固制品和装置及相关方法
    • WO2009102776A2
    • 2009-08-20
    • PCT/US2009033777
    • 2009-02-11
    • CELONOVA BIOSCIENCES INCFRITZ ULFFRITZ OLAFWOJCIK RONALDGASKINS RALPH E
    • FRITZ ULFFRITZ OLAFWOJCIK RONALDGASKINS RALPH E
    • A61B17/068A61B17/04
    • A61L31/06A61B17/06166A61B17/064A61B17/1227A61L17/06A61L17/145A61L31/10C08L85/02
    • Suitable tissue-fastening articles and devices that can incorporate and/or be encapsulated by one or more potyphosphazenes are provided, including various surgical fastening devices ('SFD'), sutures, surgical staples, screws, and other equivalent tissue-fastening devices, which exhibit exceilent mechanical and physical tolerance properties, in order to improve the biocompatibiiity of such sheathed implanted devices, and to prevent or diminish various secondary injuries following a treatment or an implantation. The poiyphosphazenes coating of various tissue-fastening articles and devices imparts substantial advantages to such articles and devices, including the prevention or minimization of uncontroiled cellular growth, and reduction in various inflammatory reactions following the implantation of a foreign material into a patient's body, and thereby, reducing the amount of antibiotics necessary to treat infections attendant with such implantation and subsequent inflammatory reactions.
    • 提供了可以包含和/或被一种或多种磷酰胺封装的合适的组织紧固制品和装置,包括各种外科紧固装置('SFD'),缝合线,外科缝合钉,螺钉以及其他等同的组织紧固装置 表现出优异的机械和物理耐受性能,以便改善这种护套植入装置的生物相容性,并预防或减少治疗或植入后的各种继发性损伤。 各种组织紧固制品和装置的聚磷腈涂层赋予这些制品和装置显着的优点,包括防止或最小化不受抑制的细胞生长,以及在将异物植入患者体内之后减少各种炎症反应,并由此 ,减少治疗伴随着这种植入和随后的炎症反应伴随的感染所必需的抗生素的量。
    • 2. 发明申请
    • VASODILATOR ELUTING DYNAMIC BLOOD HANDLING DEVICES WITH A SPECIFIC POLYPHOSPHAZENE COATING AND METHODS FOR THEIR MANUFACTURE AND USE
    • 具有特殊多磷酸涂层的血管加压器动态血液处理装置及其制造和使用方法
    • WO2009110858A2
    • 2009-09-11
    • PCT/US2007083192
    • 2007-10-31
    • CELONOVA BIOSCIENCES INCFRITZ OLAFFRITZ ULFDENK ROMANWILSON TERESAGASKINS RALPH E
    • FRITZ OLAFFRITZ ULFDENK ROMANWILSON TERESAGASKINS RALPH E
    • A61L33/06A61J1/05
    • A61L29/085C08L85/02
    • The present invention is directed to medical devices in which flow is channeled of blood and blood products for the purpose of effecting a chemical exchange to remove desired chemicals from the blood or blood products, and to impart nitric oxide, other smooth muscle relaxant compounds, or other desired chemicals to the blood or blood products to achieve vascular dilatation, reduce adverse reactions, reduce thrombosis, reduce red blood cell injuries, and improve blood handling capabilities. In the present invention, such chemical exchanges occur over semipermeable membranes associated with channeled flow of blood and blood products. Various embodiments of the present invention thus apply to the clinical settings for filters, cannulae, tubing, and blood handling components for dynamic blood handling, filtering, and processing devices including, but not limited to, cardiopulmonary bypass pumps, left ventricular assist devices, artificial hearts, ECMO devices, renal or hepatic hemodialysis systems, and hemofiltration systems.
    • 本发明涉及医疗装置,其中为了进行化学交换以从血液或血液制品中除去所需化学物质,以及赋予一氧化氮,其它平滑肌松弛剂化合物或血液和血液制品 其他需要化学物质的血液或血液制品实现血管扩张,减少不良反应,减少血栓形成,减少红细胞损伤,改善血液处理能力。 在本发明中,这种化学交换发生在与血液和血液制品的通道流动相关的半透膜上。 因此,本发明的各种实施例适用于用于动态血液处理,过滤和处理装置的过滤器,套管,管道和血液处理组件的临床设置,包括但不限于体外循环泵,左心室辅助装置,人造 心脏,ECMO装置,肾或肝血液透析系统和血液滤过系统。
    • 8. 发明申请
    • LOADABLE POLYPHOSPHAZENE-COMPRISING PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME
    • 用于治疗和/或诊断应用的负载型聚磷脂包封颗粒及其制备和使用方法
    • WO2006046155A3
    • 2006-08-17
    • PCT/IB2005004007
    • 2005-10-24
    • POLYZENIX GMBHHARDER PHILLIPFRITZ OLAFFRITZ ULF
    • HARDER PHILLIPFRITZ OLAFFRITZ ULF
    • A61K9/16A61K9/50A61K9/51
    • A61K9/5031A61K9/1641A61K9/1694A61K9/5073A61K9/5078A61K9/5089A61K49/0404A61K49/0419
    • Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy) phosphazene] and/or a derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles can also include a core having a hydrogel formed from an acrylic-based polymer. Barium sulfate may also be provided to the core of the particles as a coating or absorbed within the core of the particles. The particles can be used to minimize blood flow to mammalian tissues by occluding at least a portion of a blood vessel of the mammal, or to deliver an active agent to a localized area within a body of a mammal by contacting a localized area with at least one of the particles. Further, the particles are useful in sustained release formulations including active agent(s) for oral administration, as tracer particles for injection into the bloodstream of a mammal or for use in enhanced ultrasound imaging. The particles may include agents for increasing density for achieving useful buoyancy levels in suspension.
    • 颗粒被提供用于治疗和/或诊断过程。 颗粒包括聚[双(三氟乙氧基)磷腈]和/或其衍生物,其可以存在于整个颗粒中或颗粒的外涂层内。 颗粒还可以包括具有由丙烯酸类聚合物形成的水凝胶的芯。 也可以将硫酸钡作为涂层提供到颗粒的芯部或者被吸收在颗粒的芯中。 颗粒可以用于通过闭塞哺乳动物的血管的至少一部分来最小化对哺乳动物组织的血流,或者通过使至少一个局部区域与至少一个局部区域接触而将活性剂递送到哺乳动物体内的局部区域 其中一颗颗粒。 此外,该颗粒可用于持续释放制剂,包括用于口服给药的活性剂,作为用于注射到哺乳动物血流中的示踪剂颗粒或用于增强的超声成像。 颗粒可以包括增加密度的试剂,以实现悬浮液中有用的浮力水平。